Accolades
Sidley Ranked in Chambers Greater China Region 2026
January 15, 2026
Sidley has received 14 practice rankings and 21 lawyer rankings in Chambers Greater China Region 2026. The firm has attained a market-leading Band 1 ranking in Capital Markets: High-Yield Products (International Firms) and Life Sciences (International Firms).
The firm has also achieved rankings in the following China areas:
- Banking & Finance (International Firms)
- Capital Markets: Debt (International Firms)
- Capital Markets: Equity (International Firms)
- Corporate Investigations/Anti-Corruption (International Firms)
- Corporate/M&A: Highly Regarded (International Firms)
- Dispute Resolution: Arbitration (International Firms)
- Dispute Resolution: Litigation (International Firms)
- Financial Services (International Firms)
- Investment Funds: Hedge Funds (International Firms)
- Investment Funds: Private Equity (International Firms)
- Private Equity: Buyouts & Venture Capital Investment (International Firms)
- Restructuring/Insolvency (International Firms)
Significantly, three Sidley partners have retained their top-tier, Band 1 placements in their respective practice areas, demonstrating their positions as leading lawyers in the market.
- Carrie Li – Capital Markets: High-Yield Products (International Firms)
- Yuet Ming Tham – Corporate Investigations/Anti-Corruption (International Firms)
- Chen Yang – Life Sciences (International Firms)
The Chambers Greater China Region guide provides analysis of legal practitioners across the region based on in-depth interviews with clients and in-house counsel.
Contacts

Offices
Capabilities
Suggested News & Insights
Sidley Wins “Innovative Lawyers in Disputes” Award at the FT Innovative Lawyers Awards Asia-Pacific 2026May 14, 2026Sidley Represents GFH as Anchor Investor in the US$5 Billion Dual IPO of Pershing Square Inc. and Pershing Square USAMay 13, 2026Sidley Represents Underwriters in Connection With Pharvaris’ US$115 Million Underwritten Offering of Ordinary SharesMay 8, 2026Sidley Represents Siris Capital in Its US$4.2 Billion Sale of EquinitiMay 5, 2026Sidley Advises on Brookfield India REIT and Poonawalla Fincorp Qualified Institutions PlacementsMay 5, 2026Sidley Represents Archimed in US$1.1 Billion Acquisition of Esperion TherapeuticsMay 1, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory

